Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
23,200
+100 (0.43%)
At close: Jun 23, 2025, 3:30 PM KST
23.54%
Market Cap 158.20B
Revenue (ttm) 69.65B
Net Income (ttm) 15.30B
Shares Out 6.97M
EPS (ttm) 2,244.75
PE Ratio 10.11
Forward PE n/a
Dividend 1,500.00 (6.58%)
Ex-Dividend Date Dec 27, 2024
Volume 12,921
Average Volume 27,982
Open 23,050
Previous Close 23,100
Day's Range 22,350 - 23,250
52-Week Range 14,500 - 24,700
Beta -0.31
RSI 64.48
Earnings Date Aug 14, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.